NuCana (NCNA) Total Current Liabilities (2016 - 2025)

NuCana (NCNA) reported Total Current Liabilities of $6.4 million for Q4 2025, down 42.68% on a YoY basis from $11.1 million in Q4 2024, and down 24.66% sequentially from $8.5 million in Q3 2025.

NuCana (NCNA) Total Current Liabilities (2016 - 2025) Analysis & Trends

NuCana (NCNA) has 10 years of Total Current Liabilities data on file, last reported at $6.4 million in Q4 2025.

  • For the quarter ending Q4 2025, Total Current Liabilities fell 42.68% year-over-year to $6.4 million; the trailing twelve-month figure through Dec 2025 stood at $6.4 million (down 42.68% YoY), and the FY2025 full-year result was $6.3 million, down 42.95% from the prior year.
  • Total Current Liabilities slipped to $6.4 million in Q4 2025, from $8.5 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $22.6 million in Q4 2022 to a low of $6.4 million in Q4 2025.
  • A 5-year average of $15.0 million and a median of $15.8 million in 2021 frame the typical range for Total Current Liabilities.
  • Across the five-year window, Total Current Liabilities jumped 61.21% in 2021 and slumped 56.65% in 2025, its largest moves.
  • Tracing NCNA's Total Current Liabilities over 5 years: stood at $15.8 million in 2021, then jumped by 43.41% to $22.6 million in 2022, then sank by 30.54% to $15.7 million in 2023, then slipped by 29.3% to $11.1 million in 2024, then tumbled by 42.68% to $6.4 million in 2025.
  • Business Quant data shows NCNA's Total Current Liabilities at $6.4 million in Q4 2025, $8.5 million in Q3 2025, and $11.6 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 56.01 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 66.94 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.81 Bn
4 NuCana 279.75 Bn 279.75 Bn - 6.38 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 3.88 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 5.11 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.58 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 289.60 Mn
10 Alnylam Pharmaceuticals 35.71 Bn 32.70 Bn 959.66 Mn 1.35 Bn

Historic Data

Download Data
DateValue
Dec 31, 2025 6.38 Mn
Sep 30, 2025 8.46 Mn
Jun 30, 2025 11.60 Mn
Mar 31, 2025 9.18 Mn
Dec 31, 2024 11.12 Mn
Sep 30, 2024 19.52 Mn
Jun 30, 2024 20.27 Mn
Mar 31, 2024 18.32 Mn
Dec 31, 2023 15.73 Mn
Sep 30, 2023 15.09 Mn
Jun 30, 2023 16.94 Mn
Mar 31, 2023 20.18 Mn
Dec 31, 2022 22.65 Mn
Sep 30, 2022 18.22 Mn
Jun 30, 2022 13.14 Mn
Mar 31, 2022 16.80 Mn
Dec 31, 2021 15.79 Mn
Sep 30, 2021 16.68 Mn
Jun 30, 2021 10.98 Mn
Mar 31, 2021 12.50 Mn